ইউরোপীয় ইউনিয়ন -
সুইডিশ -
EMA (European Medicines Agency)
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - andra nervsystemet droger - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).
সুইডেন -
সুইডিশ -
Läkemedelsverket (Medical Products Agency)
campto 20 mg/ml koncentrat till infusionsvätska, lösning
pfizer ab - irinotekanhydrokloridtrihydrat - koncentrat till infusionsvätska, lösning - 20 mg/ml - irinotekanhydrokloridtrihydrat 20 mg aktiv substans; sorbitol hjälpämne - irinotekan
সুইডেন -
সুইডিশ -
Läkemedelsverket (Medical Products Agency)
campto 20 mg/ml koncentrat till infusionsvätska, lösning
orifarm ab - irinotekanhydrokloridtrihydrat - koncentrat till infusionsvätska, lösning - 20 mg/ml - sorbitol hjälpämne; irinotekanhydrokloridtrihydrat 20 mg aktiv substans - irinotekan
সুইডেন -
সুইডিশ -
Läkemedelsverket (Medical Products Agency)
irinokabi 20 mg/ml koncentrat till infusionsvätska, lösning
fresenius kabi ab - irinotekanhydrokloridtrihydrat - koncentrat till infusionsvätska, lösning - 20 mg/ml - irinotekanhydrokloridtrihydrat 20 mg aktiv substans; sorbitol hjälpämne - irinotekan
সুইডেন -
সুইডিশ -
Läkemedelsverket (Medical Products Agency)
irinosor 20 mg/ml koncentrat till infusionsvätska, lösning
ratiopharm gmbh - irinotekanhydrokloridtrihydrat - koncentrat till infusionsvätska, lösning - 20 mg/ml - irinotekanhydrokloridtrihydrat 20 mg aktiv substans; sorbitol hjälpämne - irinotekan
সুইডেন -
সুইডিশ -
Läkemedelsverket (Medical Products Agency)
campto 20 mg/ml koncentrat till infusionsvätska, lösning
orifarm ab - irinotekanhydrokloridtrihydrat - koncentrat till infusionsvätska, lösning - 20 mg/ml - irinotekanhydrokloridtrihydrat 20 mg aktiv substans; sorbitol hjälpämne - irinotekan
সুইডেন -
সুইডিশ -
Läkemedelsverket (Medical Products Agency)
campto 20 mg/ml koncentrat till infusionsvätska, lösning
orifarm ab - irinotekanhydrokloridtrihydrat - koncentrat till infusionsvätska, lösning - 20 mg/ml - irinotekanhydrokloridtrihydrat 20 mg aktiv substans; sorbitol hjälpämne - irinotekan
সুইডেন -
সুইডিশ -
Läkemedelsverket (Medical Products Agency)
namedica 20 mg/ml koncentrat till infusionsvätska, lösning
regiomedica gmbh - irinotekanhydrokloridtrihydrat - koncentrat till infusionsvätska, lösning - 20 mg/ml - irinotekanhydrokloridtrihydrat 20 mg aktiv substans; sorbitol hjälpämne - irinotekan
ইউরোপীয় ইউনিয়ন -
সুইডিশ -
EMA (European Medicines Agency)
lonsurf
les laboratoires servier - trifluridine, tipiracil hydroklorid - kolorektala neoplasmer - antineoplastiska medel - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.
সুইডেন -
সুইডিশ -
Läkemedelsverket (Medical Products Agency)
capecitabine intas 150 mg filmdragerad tablett
intas pharmaceuticals limited - kapecitabin - filmdragerad tablett - 150 mg - kapecitabin 150 mg aktiv substans; laktos (vattenfri) hjälpämne - kapecitabin